Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients

Stopped Preliminary data analysis showed insufficient efficacy to justify continuation.

Conditions

• Transplant
• Intraocular Pressure

Interventions

• DRUG: anecortave acetate
• DRUG: 30 mg anecortave acetate

Sponsor

Cornea Research Foundation of America